Get the Stockscreener App
0.391
0.00%
0.00
Silo Pharma Inc stock is traded at $0.391, with a volume of 117.15K.
It is up +0.00% in the last 24 hours and down -21.80% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
See More
Previous Close:
$0.391
Open:
$0.3981
24h Volume:
117.15K
Relative Volume:
0.03
Market Cap:
$6.49M
Revenue:
$72,100
Net Income/Loss:
$-4.23M
P/E Ratio:
-0.6442
EPS:
-0.607
Net Cash Flow:
$-4.66M
1W Performance:
+4.83%
1M Performance:
-21.80%
6M Performance:
-13.13%
1Y Performance:
-8.84%
1-Day Range:
$0.391
$0.4153
1-Week Range:
$0.36
$0.4153
52-Week Range:
$0.221
$1.01
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.21 | 2.93B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
7.83 | 432.93M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.15 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
3.29 | 288.61M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
47.62 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Stock (SILO) Latest News
Silo Pharma Inc. (SILO) Q4 2023 Earnings: Widening Losses as Pre-Revenue Biotech Focuses on Pipeline ProgressProfit Margin Analysis - Newser
SILO Q4 2023 Earnings: Biotech Misses EPS Estimates as Pre‑Revenue Phase ContinuesCrowd Stock Picks - Newser
Silo Pharma Inc. (SILO) Edges Higher as Shares Test Key ResistanceAggressive Growth Picks - Newser
Silo Pharma (SILO) Q4 2023 Results Disappoint: What Investors Should KnowLive Trade Sharing - Newser
Silo Pharma (SILO) Q4 2023 Earnings: Miss Sparks ConcernTrending Entry Points - Newser
Silo Pharma, Inc. (SILO) Q1 2026 10-Q: Financials, Crypto Asset Holdings, and Business Developments - Minichart
Silo Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
SILO Technical Analysis | Trend, Signals & Chart Patterns | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
Silo Pharma (NASDAQ: SILO) Q1 loss widens as R&D and crypto costs rise - Stock Titan
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative - citybuzz -
Silo Pharma files patent for ibogaine-based TBI treatment By Investing.com - Investing.com Australia
Silo Pharma files patent for ibogaine-based TBI treatment - Investing.com
With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - ChartMill
Silo Pharma rallies after securing key patent allowance - MSN
SILO Stock Price, Quote & Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
SILO Silo Pharma reports wider-than-expected Q4 2023 loss, shares dip 1.62% amid weak investor sentiment.High Attention Stocks - Newser
Silo Pharma’S Ptsd Program Advances As FDA Fast-Tracks Psychedelic Therapies For Ptsd - TradingView
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - GlobeNewswire
Washington speeds psychedelic PTSD work as Silo spotlights program - Stock Titan
Why did SILO stock soar 85% today? - MSN
Levi Strauss, Greenbrier and 3 stocks to watch heading into Tuesday - MSN
SILO Silo Pharma rises 5.57 percent despite reporting a wider than expected Q4 2023 per share loss.Gross Margin - Newser
CMND stock set for biggest intraday gains in over three years — here’s why retail is eyeing further upside - MSN
SILO Price Today: Silo Pharma, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAxe Compute (NASDAQ:AGPU), Akanda (NASDAQ - Benzinga
Silo Pharma launches AI subsidiary, advances PTSD drug program By Investing.com - Investing.com India
AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Into AI With Qwikagents Asset Acquisition - FinancialContent
Silo Pharma Inc. posts 76.5% EPS miss with no reported revenueDividend Initiation - Cổng thông tin điện tử tỉnh Tây Ninh
Is Southern (SOJD) stock recovering momentum | Q3 2000: Profit SurprisesDecline Phase - Xã Thanh Hà
Silo Pharma launches AI subsidiary, advances PTSD drug program - Investing.com
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents - The Manila Times
A biotech advancing a PTSD drug just bought an AI agent platform - Stock Titan
Silo Pharma, Inc. acquired Assets of Qwikagents.ai. - marketscreener.com
Silo Pharma highlights PTSD treatment program amid policy shift By Investing.com - Investing.com India
Silo Pharma highlights PTSD drug program amid policy shift By Investing.com - Investing.com India
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics - marketscreener.com
Silo Pharma (SILO) Stock Payout Ratio (Momentum Building) 2026-04-20Buy Signals - Cổng thông tin điện tử tỉnh Lào Cai
Silo Pharma highlights PTSD drug program amid policy shift - Investing.com
Silo Pharma highlights PTSD treatment program amid policy shift - Investing.com
Silo Pharma Positioned to Advance Treatment Targeting PTSD - GlobeNewswire
Silo Pharma (SILO) Stock VWAP Break (+1.18%) 2026-04-18Community Breakout Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Is Silo Pharma (SILO) stock a smart investment (Bullish Momentum) 2026-04-18Income Investing - Newser
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Silo Pharma Inc Stock (SILO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.37 |
1,000 |
370 |
210,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
| Weisblum Eric | Chief Executive Officer |
May 27 '25 |
Buy |
0.43 |
10,000 |
4,329 |
197,932 |
2.25%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):